Cosmo S.p.A. cosmospa.it


Public lists: Pharma Startups (4740)

Cosmo is a fully-integrated speciality pharmaceutical company that aims to become engaged in the market of optimised therapies for selected gastro-intestinal diseases. The company's clinical development pipeline specifically addresses treatments for Inflammatory Bowel Diseases (IBD), such as Ulcerative Colitis and Crohn's Disease, as well as for colon infections.

Cosmo is a fully-integrated speciality pharmaceutical company that aims to become engaged in the market of optimised therapies for selected gastro-intestinal diseases. The company's clinical development pipeline specifically addresses treatments for ...Show all

Company (Alive / Active)

Phone:

Fax:

Cosmo Pharmaceuticals S.p.A.
Via C. Colombo 1
20020
Italy

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cosmo S.p.A. $0M Mar 19, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cosmo S.p.A. Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives Nov 07, 2013 Sep 06, 2016 Patent
17alfa, 21-dihydroxypregnene esters as antiandrogenic agents Dec 11, 2013 Oct 21, 2014 Patent
17α, 21-dihydroxypregnene esters as antiandrogenic agents Jun 24, 2009 Mar 27, 2012 Patent